# Connor McDermott

> Connor McDermott is a Series B investor at Northpond Ventures backing Medical and Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Northpond Ventures](https://shizune.co/investors/profile/northpond-ventures)
- Total investments: 1
- Last investment: Dec 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/connor-mcdermott-421467108/

Connor McDermott is a Series B investor at Northpond Ventures focused on Medical and Biopharma. Connor McDermott - Vice President @ Northpond Ventures

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Biopharma | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Totus Medicines | Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases across the entire human genome. | $66M | Series B | Dec 15, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [DCVC Bio](https://shizune.co/investors/profile/dcvc-bio) — VC Fund, 3 deals together
- [Camford Capital](https://shizune.co/investors/profile/camford-capital) — VC Fund, 1 deal together
- [Regents of The University of Minnesota](https://shizune.co/investors/profile/regents-of-the-university-of-minnesota) — VC Fund, 1 deal together

## About Northpond Ventures

VC Fund · Bethesda, United States

Northpond Ventures is a science-driven venture capital firm headquartered in Bethesda, Maryland. Our mission is to build a better tomorrow. Our investments are focused on life sciences, technology, and affiliated industries.

5 contacts available at Northpond Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Adam Wieschhaus | Director | https://shizune.co/investors/profile/adam-wieschhaus |
| Andrew Lee | Managing Director | https://shizune.co/investors/profile/andrew-lee-0d23 |
| Connor McDermott | Vice President | https://shizune.co/investors/profile/connor-mcdermott |
| Karthik Bolisetty | Senior Associate | https://shizune.co/investors/profile/karthik-bolisetty |
| Michael Rubin | Founder & CEO | https://shizune.co/investors/profile/michael-rubin-5 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Connor McDermott invest in?

Connor McDermott invests primarily in Medical, Biopharma and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Connor McDermott last invest?

The most recent investment recorded for Connor McDermott closed in Dec 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co